| Literature DB >> 31036694 |
Chand S Mangat1, Sadjia Bekal2, Brent P Avery3, Geneviève Côté4, Danielle Daignault5, Florence Doualla-Bell2, Rita Finley3, Brigitte Lefebvre2, Amrita Bharat1, E Jane Parmley3, Richard J Reid-Smith3, Jean Longtin2, Rebecca J Irwin3, Michael R Mulvey6.
Abstract
Salmonella enterica subsp. enterica serovar Dublin is a zoonotic pathogen that often leads to invasive bloodstream infections in humans that are multidrug resistant. Described here are the results of Canadian national surveillance of S Dublin from 2003 to 2015 in humans and bovines, principally collected through the Canadian Integrated Program for Antibiotic Resistance Surveillance (CIPARS). An increase in human infections due to multidrug-resistant (MDR) S Dublin was observed in 2010, many of which were bloodstream infections. Phylogenomic analysis of human and bovine isolates revealed a closely related network that differed by only 0 to 17 single nucleotide variants (SNVs), suggesting some potential transmission between humans and bovines. Phylogenomic comparison of global publicly available sequences of S Dublin showed that Canadian isolates clustered closely with those from the United States. A high correlation between phenotypic and genotypic antimicrobial susceptibility was observed in Canadian isolates. IS26 replication was widespread among U.S. and Canadian isolates and caused the truncation and inactivation of the resistance genes strA and bla TEM-1B A hybrid virulence and MDR plasmid (pN13-01125) isolated from a Canadian S Dublin isolate was searched against NCBI SRA data of bacteria. The pN13-01125 coding sequences were found in 13 Salmonella serovars, but S Dublin appears to be a specific reservoir. In summary, we have observed the rise of invasive MDR S Dublin in humans in Canada and found that they are closely related to bovine isolates and to American isolates in their mobile and chromosomal contents. © Crown copyright 2019.Entities:
Keywords: Salmonellazzm321990; antimicrobial resistance; genomics
Mesh:
Year: 2019 PMID: 31036694 PMCID: PMC6535508 DOI: 10.1128/AAC.00108-19
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191